| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.6 |